Amylon Therapeutics
Company Description
Amylon Therapeutics is a biotechnology company that targets CNS disorders through an ultra-genetics approach.
Amylon Therapeutics is a biotechnology company that targets CNS disorders through an ultra-genetics approach, focusing on rare genetic disorders that can serve as a possible gateway to more frequently occurring indications. Amylon is led by founder Thomas de Vlaam, complemented by a scientific board of experienced scientists and biotech veterans. The company was founded in 2017 and is based in Leiden, Zuid-Holland, The Netherlands.
-
Manufacturer:
Science and Engineering -
Company Website:
-
Company E-mail:
-
Company Address:
Zernikedreef 9,LeidenNetherlands -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits